ArticleHuman molecular genetics2016

Germline missense pathogenic variants in the BRCA1 BRCT domain, p.Gly1706Glu and p.Ala1708Glu, increase cellular sensitivity to PARP inhibitor olaparib by a dominant negative effect.

Tereza Vaclová et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.